Bristol-Myers Squibb Company Ce
Bristol-Myers Squibb Company Ce
- Market cap
- $143.23B
- P/E ratio
- 13.26
Your view on CELG-RI
Overview
What the company does, where it operates, and who runs it.
About Bristol-Myers Squibb Company Ce
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Christopher S. Boerner
- Headquarters
- US
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Christopher S. Boerner
- Headquarters
- US
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies.
The company was founded in August 1933 and is headquartered in Princeton, NJ.
Stock Data
Price chart, volume, and trading data.
FRC Fair Value Algorithm
What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.
About this section
Fair value for Bristol-Myers Squibb Company Ce from FRC's valuation model, read against the market price. CELG-RI last traded at $0.16, 13.3× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Bristol-Myers Squibb Company Ce. Starting points for Bristol-Myers Squibb Company Ce: P/E 13.3, EPS $4.52, beta -0.47 — an Medical - Pharmaceuticals name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Bristol-Myers Squibb Company Ce. Trailing twelve-month EPS for Bristol-Myers Squibb Company Ce stands at $4.52. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.
Earnings Estimate
| EPS | Current QtrDec 2026 | Next QtrMar 2027 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | $1.59 | $1.45 | $6.93 | $6.55 |
| Low estimate | $1.59 | $1.45 | $6.93 | $6.55 |
| High estimate | $1.59 | $1.45 | $6.93 | $6.55 |
| No. of analysts | 1 | 1 | 1 | 1 |
| Year-ago EPS | $1.26 | $1.58 | $3.45 | — |
| Growth | +26.5% | −8.2% | +100.8% | — |
Revenue Estimate
| Revenue | Current QtrDec 2026 | Next QtrMar 2027 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | $12.64B | $11.16B | $49.55B | $48.07B |
| Low estimate | $12.64B | $11.16B | $49.55B | $48.07B |
| High estimate | $12.64B | $11.16B | $49.55B | $48.07B |
| No. of analysts | 1 | 1 | 1 | 1 |
| Year-ago revenue | $12.50B | $11.49B | $48.20B | — |
| Growth | +1.1% | −2.9% | +2.8% | — |
Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep; as of Nov 20, 2026. Not FRC research or a recommendation.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Bristol-Myers Squibb Company Ce. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | Mkt cap |
|---|---|---|---|---|---|
| AMGNAmgen Inc. | Healthcare | Drug Manufacturers - General | $240.1B | ||
| CVSCVS Health Corporation | Healthcare | Medical - Healthcare Plans | $104.1B | ||
| GILDGilead Sciences, Inc. | Healthcare | Drug Manufacturers - General | $209.6B | ||
| GSKGSK plc | Healthcare | Drug Manufacturers - General | $97.5B | ||
| HCAHCA Healthcare, Inc. | Healthcare | Medical - Care Facilities | $99.5B | ||
| MCKMcKesson Corporation | Healthcare | Medical - Distribution | $125.2B | ||
| MDTMedtronic plc | Healthcare | Medical - Devices | $128.8B | ||
| PFEPfizer Inc. | Healthcare | Drug Manufacturers - General | $159.9B | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| HTPRFHTC Purenergy Inc. | Healthcare | OTC | $8,153 | ||
| HTSUYHisamitsu Pharmaceutical Co., Inc. | Healthcare | OTC | $1.9B | ||
| HYHYHydrogen Hybrid Technologies, Inc. | Healthcare | OTC | $9,375 | ||
| INBPIntegrated BioPharma, Inc. | Healthcare | OTC | $8.5M | ||
| INNO.CNInnoCan Pharma Corporation | Healthcare | CNQ | $36.1M | ||
| IPAHInterpharm Holdings, Inc. | Healthcare | OTC | $270,768 | ||
| ISHIIslet Holdings, Inc. | Healthcare | OTC | $5 | ||
| ITNSItonis, Inc. | Healthcare | OTC | $761,705 | ||
| IYXIInyx, Inc. | Healthcare | OTC | $5,234 | ||
| JDHIFJD Health International Inc. | Healthcare | OTC | $24.3B | ||
| JDHIYJD Health International Inc. | Healthcare | OTC | $29.1B | ||
| KNSAKiniksa Pharmaceuticals, Ltd. | Healthcare | NASDAQ | $7.5B | ||
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold Bristol-Myers Squibb Company Ce, and how their positions are changing. At a $143.23B market value, institutional positions materially move Bristol-Myers Squibb Company Ce's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by Bristol-Myers Squibb Company Ce executives and directors. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Bristol-Myers Squibb Company Ce. Coverage tracks Bristol-Myers Squibb Company Ce within Medical - Pharmaceuticals (Healthcare). Press releases and market coverage, newest first.
Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Bristol-Myers Squibb Company Ce.